Company Profile

  1. You are here:    Home
  2. Search Databases
  3. Search Company Registry
  4. Company Profile

Ixion Biotechnology Inc
Profile last edited on: 6/10/2011      CAGE: 47HP4      UEI: Q1F3TP2KN672

Business Identifier: NO Business Identifier is currently available for this company.
Year Founded
1993
First Award
1996
Latest Award
2006
Program Status
Inactive
Popularity Index

Edit Company Profile

Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
  Explanation Edit

Location Information

13709 Progress Boulevard Box 13 Suite 207
Alachua, FL 32615
   (904) 418-1428
   info@ixion-biotech.com
   www.ixion-biotech.com
Location: Single
Congr. District: 03
County: Alachua

Public Profile

Research and development organization specializing in the development of orally administered enzymes that promote oxalate degradation. The company focuses on diabetes and disease caused by the body's failure to break down oxalates. Its diabetes research centers on the transplantation of glucose-regulating cells. The firm has since closed and is operating as OxThera, Inc.

Extent of SBIR involvement

User Avatar
Phase I Awards
9
Phase II Awards
5
Conversion Rate
55.56%
Phase I Dollars
$1,080,815
Phase II Dollars
$3,330,736
Total Awarded
$4,411,551

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
5-9

Awards Distribution by Agency

Most Recent SBIR Projects
Year Phase Agency Total Amount
2006 1 NIH $188,420
Project Title: Conversion of long-term cultured human pancreatic cells into functional islets
2004 2 NIH $863,566
Project Title: Coating Of Urinary Protheses To Prevent Encrustation
2003 2 NIH $604,690
Project Title: M3 Receptor: Diagnostic Marker For Sjogren's Syndrome
2003 2 NIH $974,502
Project Title: Oxalobacter Formigenes Diagnostic Kit Development
2002 2 NIH $604,660
Project Title: Enteric Elimination Of Oxalic Acid

Key People / Management

  Weaver H Gaines -- CEO

  Robert G Harris

  Marguerite Hatch

  Michael Humphreys-Beher

  Stephen Maddocks

  Vijayakumar K Ramiya

  Harmeet Sidhu

  Li Yin

Company News

There are no news available.